510 related articles for article (PubMed ID: 9619797)
21. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy.
Burdick AE; Carmichael C; Rady PL; Tyring SK; Badiavas E
J Am Acad Dermatol; 1997 Oct; 37(4):648-9. PubMed ID: 9344209
[No Abstract] [Full Text] [Related]
22. Drugs for HIV infection.
Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
[No Abstract] [Full Text] [Related]
23. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
Boivin G; Gaudreau A; Routy JP
AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
[TBL] [Abstract][Full Text] [Related]
24. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
Wit FW; Sol CJ; Renwick N; Roos MT; Pals ST; van Leeuwen R; Goudsmit J; Reiss P
AIDS; 1998 Jan; 12(2):218-9. PubMed ID: 9468373
[No Abstract] [Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
26. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
27. Antiretroviral chemotherapy.
Saag MS; Schooley RT
Curr Clin Top Infect Dis; 1998; 18():154-79. PubMed ID: 9779354
[No Abstract] [Full Text] [Related]
28. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
[TBL] [Abstract][Full Text] [Related]
29. Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.
Schwartz JD; Howard W; Scadden DT
AIDS; 1999 Feb; 13(2):283-4. PubMed ID: 10202837
[No Abstract] [Full Text] [Related]
30. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease.
Piketty C; Castiel P; Belec L; Batisse D; Si Mohamed A; Gilquin J; Gonzalez-Canali G; Jayle D; Karmochkine M; Weiss L; Aboulker JP; Kazatchkine MD
AIDS; 1998 May; 12(7):745-50. PubMed ID: 9619806
[TBL] [Abstract][Full Text] [Related]
31. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy.
Jung C; Bogner JR; Goebel F
Eur J Med Res; 1998 Sep; 3(9):439-42. PubMed ID: 9737891
[TBL] [Abstract][Full Text] [Related]
32. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
33. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" Study.
Lafeuillade A; Poggi C; Chadapaud S; Hittinger G; Chouraqui M; Delbeke E;
J Acquir Immune Defic Syndr; 2001 Oct; 28(2):154-7. PubMed ID: 11588509
[TBL] [Abstract][Full Text] [Related]
35. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
[TBL] [Abstract][Full Text] [Related]
36. HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
Broccolo F; Tassan Din C; Viganò MG; Rutigliano T; Esposito S; Lusso P; Tambussi G; Malnati MS
J Clin Virol; 2016 May; 78():47-52. PubMed ID: 26985593
[TBL] [Abstract][Full Text] [Related]
37. Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals.
Kaufmann GR; Duncombe C; Cunningham P; Beveridge A; Carr A; Sayer D; French M; Cooper DA
AIDS; 1998 Sep; 12(13):1625-30. PubMed ID: 9764781
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus.
Wintergerst U; Hoffmann F; Sölder B; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH
Pediatr Infect Dis J; 1998 Jun; 17(6):495-9. PubMed ID: 9655541
[TBL] [Abstract][Full Text] [Related]
39. Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.
Jensen-Fangel S; Kirk O; Larsen L; Blaxhult A; Gerstoft J; Pedersen C; Black FT; Lundgren JD; Obel N
Scand J Infect Dis; 1999; 31(5):489-93. PubMed ID: 10576129
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study).
Cohen Stuart JW; Schuurman R; Burger DM; Koopmans PP; Sprenger HG; Juttmann JR; Richter C; Meenhorst PL; Hoetelmans RM; Kroon FP; Bravenboer B; Hamann D; Boucher CA; Borleffs JC
AIDS; 1999 May; 13(7):F53-8. PubMed ID: 10357371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
